Avidity Biosciences' Series A Round

Avidity Biosciences raised a round of funding on February 18, 2014.

Avidity Biosciences, formerly Avidity NanoMedicines, is a privately held biotech company discovering a new class of precision medicines – Antibody-siRNA Conjugates (ASC) – which combine the streng…

Articles about Avidity Biosciences' Series A Round: